Shangbay Capital is a venture capital firm focused on early-stage investments in medical devices, biotechnology, and healthcare technology sectors. Based in the heart of innovation, the firm primarily targets companies in the United States and China, providing venture equity participation to promising startups in these fields.

The firm's portfolio includes notable companies such as Ceribell, Flare Therapeutics, and Noah Medical. Shangbay Capital emphasizes building relationships with best-in-class investors, entrepreneurs, key opinion leaders, and industry innovators. Their investment philosophy centers on identifying disruptive companies addressing high-impact challenges in healthcare, supporting founders with the potential to revolutionize the industry.